Krishna Institute of Medical Sciences (KIMS) — Board Meeting

📢 Key Event
KIMS AGM approved FY2026 financials, ₹650 Cr loan/guarantee limits, and auditor remuneration

🔄 What Changed
₹650 Cr loan/guarantee approval beyond Section 186 limits

🔮 What's Next
None

💡 Investor Takeaway
Shareholders approved expanded financial assistance powers for group companies up to ₹650 Cr.

KIMS held its 24th AGM on 27 August 2026 via video conference, adopting FY2026 standalone and consolidated financial statements, reappointing Director Dandamudi Anitha, and approving loans/guarantees up to ₹650 Cr under Section 185. Shareholders also ratified cost auditor remuneration of ₹6.00 Lakhs for M/s. Sagar & Associates and authorized investment limits under Section 186. Remote e-voting occurred from 24-26 August 2026, with voting methods across NSDL, CDSL, and institutional platforms. The meeting emphasized arm's-length fund usage and Audit Committee monitoring.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KIMS ✨ Ask AI About This

About Krishna Institute of Medical Sciences Limited (KIMS)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹30,476.58 Cr P/E: 80.3

View full KIMS stock details →

📡 Get AI alerts when KIMS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KIMS — Free

💡 Ask AI about this filing

"How will the ₹650 Cr loan approvals impact KIMS's balance sheet and leverage ratios?" "What specific projects or subsidiaries will receive these loans or guarantees?" "How does this resolution compare to peer companies' related party transaction approvals?"

Ask AI Free →

📊 More KIMS filings

See all KIMS filings →

🔥 Also filed on 5 August 2026

BEL Bharat Electronics Limited Corporate Action GREAVESCOT Greaves Cotton Limited Financial Results RPTECH Rashi Peripherals Limited Financial Results MAYURUNIQ Mayur Uniquoters Ltd Annual Report RELINFRA Reliance Infrastructure Limited Announcement HINDALCO Hindalco Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KIMS files new disclosures

Track KIMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.